Moderna Stock News

Hy-Vee Inc. announced Friday that free Pfizer-BioNTech, Moderna and Janssen (J&J) COVID-19 vaccine booster doses are now available to all individuals ages 18 and older at Hy-Vee Pharmacy locations across its eight-state region. The U.S. Food & Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) recommend a booster dose for Pfizer-BioNTech and [] The post Hy-Vee offering free boosters to all 18 and up appeared first on Albert Lea Tribune .

Sound Income Strategies LLC boosted its position in shares of Moderna, Inc. (NASDAQ:MRNA) by 82.7% in the third quarter, Holdings Channel.com reports. The firm owned 645 shares of the companys stock after acquiring an additional 292 shares during the period. Sound Income Strategies LLCs holdings in Moderna were worth $248,000 as of its most recent []

SOA Wealth Advisors LLC. lifted its stake in Moderna, Inc. (NASDAQ:MRNA) by 373.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 521 shares of the companys stock after buying an additional 411 shares during the period. SOA Wealth Advisors LLC.s holdings []

Federal and state officials announced that Covid-19 Pfizer and Moderna booster shots are approved for all adults who are at least 18 years old in the United States. The Food and Drug Administration said in a press release Friday that it has amended its emergency use authorizations for Pfizer and Moderna to authorize a single [] The post Covid-19 Booster Shots Have Been Approved For All Adults appeared first on Honolulu Ci

Piscataqua Savings Bank lowered its holdings in Moderna, Inc. (NASDAQ:MRNA) by 21.4% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 275 shares of the companys stock after selling 75 shares during the quarter. Piscataqua Savings Banks holdings in Moderna were worth $106,000 at the []

WASHINGTON, D. C.: The United States authorized the Pfizer and Moderna Covid vaccine boosters for all people aged 18 and older on Friday as the world''s hardest-hit country enters a new winter wave of the pandemic. Boosters were previously available to the immune compromised, people over 65, those at high risk of severe disease and people in high risk occupations. The new decision "helps to provide continued protection against Covid-19, including the serious consequences that can occur, such as hospitalization and death," acting commissioner Janet Woodcock of the Food and Drug Administration (FDA) said. A panel of experts convened by the Centers for Disease Control and Prevention (CDC) then ratified the decision to broaden eligibility, while explicitly recommending boosters for all people over 50, even absent underlying conditions. "I am really glad that we have clarity and streamlining of the recommendations so that all Americans can understand the vaccines that are recommended for them at this time," said Camille Kotton, an infectious disease clinician at Massachusetts General Hospital.

Carroll Financial Associates Inc. trimmed its position in shares of Moderna, Inc. (NASDAQ:MRNA) by 41.3% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 249 shares of the companys stock after selling 175 shares during the quarter. Carroll Financial Associates Inc.s holdings in Moderna were []

Singapore''s minister of health says a study in the country shows Pfizer recipients who get Moderna for their third shot have even more protection from the virus.

New York, Nov 20 (IANS) The United States Centers for Disease Control and Prevention (CDC) endorsed booster doses of Pfizer/BioNTechs and Modernas Covid-19 vaccines for all US adults. CDC continues to encourage the 47 million adults who are not yet vaccinated to get vaccinated as soon as possible to protect themselves, their families, loved ones [] The post US CDC authorizes Covid-19 vaccine boosters for all adults appeared first on Buziness Bytes .

The Food and Drug Administration (FDA) and Center for Disease Control (CDC) agencies have approved Pfizer and Modernas booster shots for all adults in the United States. All persons aged 18 and older are now

The FDA has now approved Pfizer''s and Moderna''s covid boosters for individuals 18 years of age and older. ABC''s Morgan Norwood reports.

COVID Is Over (If You Want It) Submitted by QTR''s Fringe Finance The title of this blog post is, of course, an homage to the classic John Lennon Christmas song Happy XMas (War is Over) , which then spurred the popularity of the phrase War is Over! (If You Want It). Despite my distaste for Yoko Ono (and John Lennon being one of my least favorite Beatles), the song is undeniably one of the greatest ever written, both musically and lyrically. Its chorus, including the background lyrics war is over, if you want it, sung by the Harlem Community Choir, deliver a goosebump-inducing message of peace at the time of year where so many people, of varying walks of life, celebrating any number of holidays, realign themselves with the magic of giving, the importance of family, the closeness of community and a sense of purpose about our short journey here on Earth. I caught myself by surprise a couple days ago when the first Christmas playlist I put on this year pumped out this song and I started to get a little emotional.

NBC News published this video item, entitled FDA Read more

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens announced today that all individuals over the age of 18 can now receive a Pfizer, Moderna or Johnson & Johnson COVID-19 vaccine booster in stores nationwide. This follows the Food and Drug Administrations (FDA) recent decision to expand Emergency Use Authorization for Pfizer and Moderna booster vaccines to all individuals 18 and older, in addition to new guidance from the Centers for Disease Control and Prevention (CDC). Individuals can schedule

The FDA amended emergency use authorizations (EUAs) for the Moderna Inc. COVID-19 vaccine as well as the shot from Pfizer Inc. and Biontech SE. A single booster dose was green-lighted for people 18 years and older at least six months after finishing the primary regimen with either of the vaccines, or at least two months after getting the Johnson & Johnson shot.